Australia markets closed

Theratechnologies Inc. (THTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.30000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 60.59M
Enterprise value 79.17M
Trailing P/E N/A
Forward P/E 55.87
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.42
Price/book (mrq)N/A
Enterprise value/revenue 0.97
Enterprise value/EBITDA -8.03

Trading information

Stock price history

Beta (5Y monthly) 1.78
52-week change 3-63.48%
S&P500 52-week change 322.36%
52-week high 34.3200
52-week low 30.8800
50-day moving average 31.4158
200-day moving average 31.6538

Share statistics

Avg vol (3-month) 334.68k
Avg vol (10-day) 317.87k
Shares outstanding 545.98M
Implied shares outstanding 646.61M
Float 827.2M
% held by insiders 16.29%
% held by institutions 150.73%
Shares short (15 Apr 2024) 424.08k
Short ratio (15 Apr 2024) 40.8
Short % of float (15 Apr 2024) 40.05%
Short % of shares outstanding (15 Apr 2024) 40.05%
Shares short (prior month 15 Mar 2024) 417.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 331 July 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin -23.04%
Operating margin (ttm)-13.82%

Management effectiveness

Return on assets (ttm)-4.55%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)78.1M
Revenue per share (ttm)2.39
Quarterly revenue growth (yoy)-18.40%
Gross profit (ttm)N/A
EBITDA -2.94M
Net income avi to common (ttm)-18M
Diluted EPS (ttm)-0.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.45M
Total cash per share (mrq)0.84
Total debt (mrq)59.14M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.15
Book value per share (mrq)-0.54

Cash flow statement

Operating cash flow (ttm)-4.05M
Levered free cash flow (ttm)-1.96M